Journal of the Korean Association of Oral and Maxillofacial Surgeons

The Korean Association of Oral and Maxillofacial Surgeons (대한구강악안면외과학회)
권호 표지
DOI QR코드

DOI QR Code

Factors to consider for surgical in elderly patients with oral cancer

  • Lee, Sung-Tak (Department of Oral and Maxillofacial Surgery, School of Dentistry, Kyungpook National University) ;
  • Kim, Jin-Wook (Department of Oral and Maxillofacial Surgery, School of Dentistry, Kyungpook National University)
  • Received : 2020.09.09
  • Accepted : 2020.12.01
  • Published : 2021.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

At present, in Korea, due to developments in medicine and technology and an increasing mean lifespan, the expected lifetime for elderly people is increasing (at 70 years, the expected additional lifespan is 14.8 years for males and 18.3 years for females). However, among all causes of death, malignant neoplasm is ranked first for all ages. Further, the incidence rate of oral cancer tends to increase with age. Thus, oral and maxillofacial surgeons have increased opportunity to experience the 'oldest old' patients with oral cancer. Elderly patients commonly have several comorbidities, poor general condition, limited socioeconomic support, fear of various postoperative complications, and perception of short for the rest of their life. In this situation, the patient, caregiver, and surgeon often choose undergraded treatment rather than standard treatment for oral squamous cell carcinoma owing to patient age. In elderly patients with oral cancer, ablation of tumor or reconstructive surgery is challenging for surgeons. Oral and maxillofacial surgeons must evaluate carefully the patient's medical condition and make a decision regarding treatment plans after sufficient discussion with patient and caregivers. We review the literature to consider the factors involved for deciding on a treatment plan regarding surgery in elderly patients with oral cancer.

Keywords

References

  1. KKOSIS (Korean Statistical Information Service). Death rates for the 10 leading causes of death by age [Internet]. Daejeon: Statistics Korea [cited 2020 Aug 1]. Available from: https://kosis.kr/publication/publicationThema.do
  2. Boje CR, Dalton SO, Gronborg TK, Primdahl H, Kristensen CA, Andersen E, et al. The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database. Acta Oncol 2013;52:285-93. https://doi.org/10.3109/0284186X.2012.742964
  3. Chen RC, Royce TJ, Extermann M, Reeve BB. Impact of age and comorbidity on treatment and outcomes in elderly cancer patients. Semin Radiat Oncol 2012;22:265-71. https://doi.org/10.1016/j.semradonc.2012.05.002
  4. Fang QG, Shi S, Li M, Zhang X, Liu FY, Sun CF. Free flap reconstruction versus non-free flap reconstruction in treating elderly patients with advanced oral cancer. J Oral Maxillofac Surg 2014;72:1420-4. https://doi.org/10.1016/j.joms.2014.01.010
  5. Sasaki T, Moles DR, Imai Y, Speight PM. Clinico-pathological features of squamous cell carcinoma of the oral cavity in patients <40 years of age. J Oral Pathol Med 2005;34:129-33. https://doi.org/10.1111/j.1600-0714.2004.00291.x
  6. KOSIS (Korean Statistical Information Service). Cancer incident cases and incidence rates by site (24 items), sex, age group [Internet]. Daejeon: Statistics Korea [cited 2020 Aug 1]. Available from: http://kosis.kr/statHtml/statHtml.do?orgId=117&tblId=DT_117N_A00023&conn_path=I3
  7. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997;47:5-27. https://doi.org/10.3322/canjclin.47.1.5
  8. Fentiman IS. Are the elderly receiving appropriate treatment for cancer? Ann Oncol 1996;7:657-8. https://doi.org/10.1093/oxfordjournals.annonc.a010712
  9. Clayman GL, Eicher SA, Sicard MW, Razmpa E, Goepfert H. Surgical outcomes in head and neck cancer patients 80 years of age and older. Head Neck 1998;20:216-23. https://doi.org/10.1002/(sici)1097-0347(199805)20:3<216::aid-hed6>3.0.co;2-3
  10. Gambotti L, Schwob E, Schouman T, Murcier G, Goudot P, Mallet A, et al. Are elderly patients presenting with squamous cell carcinoma of the oral cavity given the appropriate treatment? Surg Oncol 2018;27:715-21. https://doi.org/10.1016/j.suronc.2018.04.005
  11. Piccirillo JF, Vlahiotis A. Comorbidity in patients with cancer of the head and neck: prevalence and impact on treatment and prognosis. Curr Oncol Rep 2006;8:123-9. https://doi.org/10.1007/s11912-006-0047-z
  12. Reid BC, Alberg AJ, Klassen AC, Samet JM, Rozier RG, Garcia I, et al. Comorbidity and survival of elderly head and neck carcinoma patients. Cancer 2001;92:2109-16. https://doi.org/10.1002/1097-0142(20011015)92:8<2109::aid-cncr1552>3.0.co;2-m
  13. Sanabria A, Carvalho AL, Vartanian JG, Magrin J, Ikeda MK, Kowalski LP. Comorbidity is a prognostic factor in elderly patients with head and neck cancer. Ann Surg Oncol 2007;14:1449-57. https://doi.org/10.1245/s10434-006-9296-1
  14. Wu Y, Zhang B, Huang Z, Ruan Y, Huang Z. Study of surgical treatment for elderly patients with head and neck cancer. Int J Oral Maxillofac Surg 2018;47:824-9. https://doi.org/10.1016/j.ijom.2018.01.018
  15. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004;291:2441-7. https://doi.org/10.1001/jama.291.20.2441
  16. Ferrier MB, Spuesens EB, Le Cessie S, Baatenburg de Jong RJ. Comorbidity as a major risk factor for mortality and complications in head and neck surgery. Arch Otolaryngol Head Neck Surg 2005;131:27-32. https://doi.org/10.1001/archotol.131.1.27
  17. Derks W, De Leeuw JR, Hordijk GJ, Winnubst JA. Elderly patients with head and neck cancer: short-term effects of surgical treatment on quality of life. Clin Otolaryngol Allied Sci 2003;28:399-405. https://doi.org/10.1046/j.1365-2273.2003.00718.x
  18. Chen JJ, Shah JL, Harris JP, Bui TT, Schaberg K, Kong CS, et al. Clinical outcomes in elderly patients treated for oral cavity squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2017;98:775-83. https://doi.org/10.1016/j.ijrobp.2017.03.017
  19. Birim O, Kappetein AP, Bogers AJ. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer. Eur J Cardiothorac Surg 2005;28:759-62. https://doi.org/10.1016/j.ejcts.2005.06.046
  20. Chang CM, Yin WY, Wei CK, Wu CC, Su YC, Yu CH, et al. Adjusted age-adjusted Charlson comorbidity index score as a risk measure of perioperative mortality before cancer surgery. PLoS One 2016;11:e0148076. https://doi.org/10.1371/journal.pone.0148076
  21. Suzuki H, Hanai N, Nishikawa D, Fukuda Y, Koide Y, Kodaira T, et al. The Charlson comorbidity index is a prognostic factor in sinonasal tract squamous cell carcinoma. Jpn J Clin Oncol 2016;46:646-51. https://doi.org/10.1093/jjco/hyw049
  22. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83. https://doi.org/10.1016/0021-9681(87)90171-8
  23. Colinet B, Jacot W, Bertrand D, Lacombe S, Bozonnat MC, Daures JP, et al.; oncoLR health network. A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index. Br J Cancer 2005;93:1098-105. https://doi.org/10.1038/sj.bjc.6602836
  24. Volk ML, Hernandez JC, Lok AS, Marrero JA. Modified Charlson comorbidity index for predicting survival after liver transplantation. Liver Transpl 2007;13:1515-20. https://doi.org/10.1002/lt.21172
  25. Roseland ME, Pressler ME, Lamerato LE, Krajenta R, Ruterbusch JJ, Booza JC, et al. Racial differences in breast cancer survival in a large urban integrated health system. Cancer 2015;121:3668-75. https://doi.org/10.1002/cncr.29523
  26. Boje CR, Dalton SO, Primdahl H, Kristensen CA, Andersen E, Johansen J, et al. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database. Radiother Oncol 2014;110:91-7. https://doi.org/10.1016/j.radonc.2013.11.009
  27. PACE participants, Audisio RA, Pope D, Ramesh HS, Gennari R, van Leeuwen BL, et al. Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol 2008;65:156-63. https://doi.org/10.1016/j.critrevonc.2007.11.001
  28. Repetto L, Fratino L, Audisio RA, Venturino A, Gianni W, Vercelli M, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 2002;20:494-502. https://doi.org/10.1200/JCO.2002.20.2.494
  29. ECOG Performance Status [Internet]. Philadelphia (PA): ECOGACRIN Cancer Research Group [cited 2021 Jan 18]. Available from: https://ecog-acrin.org/resources/ecog-performance-status
  30. Leu YS, Chang YF, Lee JC, Liu CJ, Hsiao HT, Chen YJ, et al. Squamous cell carcinoma of the oral cavity in the elderly. Int J Gerontol 2009;3:75-80. https://doi.org/10.1016/S1873-9598(09)70023-7
  31. Ferrari S, Copelli C, Bianchi B, Ferri A, Poli T, Ferri T, et al. Free flaps in elderly patients: outcomes and complications in head and neck reconstruction after oncological resection. J Craniomaxillofac Surg 2013;41:167-71. https://doi.org/10.1016/j.jcms.2012.07.005
  32. Tsai CH, Chang KP, Hung SY, Chen WF, Cheng MH, Kao HK. Postoperative morbidity in head and neck cancer ablative surgery followed by microsurgical free tissue transfer in the elderly. Oral Oncol 2012;48:811-6. https://doi.org/10.1016/j.oraloncology.2012.03.006
  33. Peters TT, Langendijk JA, Plaat BE, Wedman J, Roodenburg JL, van Dijk BA, et al. Co-morbidity and treatment outcomes of elderly pharyngeal cancer patients: a matched control study. Oral Oncol 2011;47:1159-64. https://doi.org/10.1016/j.oraloncology.2011.08.004
  34. Peters TT, van Dijk BA, Roodenburg JL, van der Laan BF, Halmos GB. Relation between age, comorbidity, and complications in patients undergoing major surgery for head and neck cancer. Ann Surg Oncol 2014;21:963-70. https://doi.org/10.1245/s10434-013-3375-x
  35. Sarini J, Fournier C, Lefebvre JL, Bonafos G, Van JT, Coche-Dequeant B. Head and neck squamous cell carcinoma in elderly patients: a long-term retrospective review of 273 cases. Arch Otolaryngol Head Neck Surg 2001;127:1089-92. https://doi.org/10.1001/archotol.127.9.1089
  36. Kim YH, Roh JL, Kim SB, Choi SH, Nam SY, Kim SY. Risk factors for competing non-cancer mortality after definitive treatment for advanced-stage head and neck cancer. Oral Dis 2018;24:1217-25. https://doi.org/10.1111/odi.12904
  37. Yang R, Lubek JE, Dyalram D, Liu X, Ord RA. Head and neck cancer surgery in an elderly patient population: a retrospective review. Int J Oral Maxillofac Surg 2014;43:1413-7. https://doi.org/10.1016/j.ijom.2014.08.008